Rossari Biotech Limited IPO – Review, Update

Update Q1 FY 2026 results   Rossari Biotech Limited, one of India’s leading specialty chemicals manufacturer has presented it Q1 FY 2026 numbers today. Here are details – The Company has posted revenue from operations of INR 543.72 Cr for the quarter ended 30 June 2025 as against revenue of INR 489.65 Cr same period… Continue reading Rossari Biotech Limited IPO – Review, Update

Exit mobile version